Compliance Rate

Compliance Rate 48.0%
Compliant submissions 48
Incompliant submissions 52
Total trials 100

Your Clinical Trials

Showing 200 of 542236 entries
View as:

Oncology Care at Home for BMT and CAR-T

Phase: N/A Priority: Normal
NCT ID: NCT05826288 Org: User:
Start: 03/29/23 End: 12/31/24 Due: 12/31/25

Nature-based Mindfulness Intervention Program for Family Carers

Phase: N/A Priority: Normal
NCT ID: NCT06302504 Org: User:
Start: 04/15/23 End: 05/31/24 Due: 05/31/25

Adolescent Substance Use Prevention Intervention Research Study in Pediatric Primary Care

Phase: N/A Priority: Normal
NCT ID: NCT04450966 Org: User:
Start: 03/10/23 End: 03/31/26 Due: 03/31/27

A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06082323 Org: User:
Start: 06/13/24 End: 06/01/25 Due: 06/01/26

Exocrine Pancreatic Insufficiency's Prevalence in Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT03915262 Org: User:
Start: 11/15/19 End: 11/15/26 Due: 11/15/27

Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients

Phase: N/A Priority: Normal
NCT ID: NCT04049851 Org: User:
Start: 04/07/22 End: 07/22/23 Due: 07/22/24

Scoliosis-Specific Exercises for At-Risk AIS Curves

Phase: N/A Priority: Normal
NCT ID: NCT02807545 Org: User:
Start: 08/02/16 End: 10/31/23 Due: 10/31/24

J-Valve Compassionate Use

Phase: N/A Priority: Normal
NCT ID: NCT03876964 Org: User:
Start: - End: - Due: -

Positron Emission Tomography (PET) Imaging with Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness

Phase: N/A Priority: Normal
NCT ID: NCT03321045 Org: User:
Start: 11/21/17 End: 10/31/27 Due: 10/31/28

Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy

Phase: N/A Priority: Normal
NCT ID: NCT05795400 Org: User:
Start: 06/01/22 End: 06/30/25 Due: 06/30/26

Outcome in Patients Treated with Intraarterial Thrombectomy - OptiMAL Blood Pressure Control (OPTIMAL-BP)

Phase: N/A Priority: Normal
NCT ID: NCT04205305 Org: User:
Start: 06/18/20 End: 07/23/23 Due: 07/23/24

Pancreatic Cancer Evolution Upon Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05195281 Org: User:
Start: 07/14/21 End: 12/31/25 Due: 12/31/26

A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02795858 Org: User:
Start: 06/14/16 End: 12/31/23 Due: 12/31/24

A Clinical Study to Check the Safety and Effectiveness of Botanical Extract Standardized for Iron + Vitamin C and Botanical Extract Standardized for Iron in Adult Human Subjects with Anemia or Iron-deficiency Anemia

Phase: N/A Priority: Normal
NCT ID: NCT06096103 Org: User:
Start: 11/03/23 End: 02/09/24 Due: 02/09/25

Efficacy of the Expectancy Challenge Alcohol Literacy Curriculum on Reducing College Student Alcohol Use and Harms

Phase: N/A Priority: Normal
NCT ID: NCT05616247 Org: User:
Start: 09/22/22 End: 09/30/25 Due: 09/30/26

Phenomenological Explorations of the Esketamine-Induced Transient Dissociative State

Phase: N/A Priority: Normal
NCT ID: NCT06133309 Org: User:
Start: 03/19/24 End: 09/30/25 Due: 09/30/26

Exploration of the Relationship Between Mismatch Repair Status of Colorectal Cancer and Lymph Node Metastasis Patterns and Pathological High-risk Factors

Phase: N/A Priority: Normal
NCT ID: NCT06798857 Org: User:
Start: 04/14/09 End: 09/09/24 Due: 09/09/25

Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement

Phase: N/A Priority: Normal
NCT ID: NCT05506878 Org: User:
Start: 10/24/22 End: 09/30/26 Due: 09/30/27

Prospective Observational Study to Evaluate Secukinumab Treatment Effectiveness in Pediatric Patients With Active Juvenile Enthesitis-related or Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT06431750 Org: User:
Start: 04/30/25 End: 08/30/28 Due: 08/30/29

Study of Individualized Physiotherapy for Airway Clearance in Cystic Fibrosis.

Phase: N/A Priority: Normal
NCT ID: NCT01266473 Org: User:
Start: 08/31/10 End: 04/30/11 Due: 04/30/12

Iribrine Plus Tucidinostat in the Treatment of HR+/HER2 Advanced Breast Cancer After CDK4/6 Inhibitor Failure

Phase: N/A Priority: Normal
NCT ID: NCT05335473 Org: User:
Start: 05/13/22 End: 11/01/25 Due: 11/01/26

Serum TWEAK Levels in Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT05684861 Org: User:
Start: 01/01/22 End: 01/01/23 Due: 01/01/24

Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions

Phase: N/A Priority: Normal
NCT ID: NCT06558825 Org: User:
Start: 10/01/24 End: 06/30/25 Due: 06/30/26

Effect of Daily Erythritol Versus Sucrose Intake Over 5 Weeks on Glucose Tolerance in Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT04966299 Org: User:
Start: 08/18/21 End: 04/30/25 Due: 04/30/26

ATL001 in Patients With Advanced Unresectable or Metastatic NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT04032847 Org: User:
Start: 07/08/19 End: 09/26/24 Due: 09/26/25